Intrinsiqs

Is ImmunityBio, Inc. overvalued?

ImmunityBio, Inc. (IBRX) — key valuation metrics and fundamentals.

No verdict
Price
$7.63
Fair value
Current P/E
Normal P/E
Market cap
$7.99B
Dividend yield
0.0%
Return on equity
135.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IBRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.